Vinflunine for the treatment of breast cancer.

about

Emerging Cytotoxic Alkaloids in the Battle against Cancer: Overview of Molecular Mechanisms.In Vitro Screening for Cytotoxic Activity of Herbal Extracts

P2860

Q39139241-CDE4434F-D40A-4FB1-A351-AF60B89B987E Q42314266-9E9A6FDA-53DD-4EB8-8B1F-DDC18997C6C9

P2860

Vinflunine for the treatment of breast cancer.

Item

http://www.wikidata.org/entity/Q38916189

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年学术文章

@wuu

2016年学术文章

@zh-cn

2016年学术文章

@zh-hans

2016年学术文章

@zh-my

2016年学术文章

@zh-sg

2016年學術文章

@yue

2016年學術文章

@zh

2016年學術文章

@zh-hant

name

Vinflunine for the treatment of breast cancer.

@en

type

Item

label

Vinflunine for the treatment of breast cancer.

@en

prefLabel

Vinflunine for the treatment of breast cancer.

@en

P1476

Vinflunine for the treatment of breast cancer.

@en

P2093

Anne Patsouris

http://www.w3.org/2001/XMLSchema#string

Carole Gourmelon

http://www.w3.org/2001/XMLSchema#string

Héloïse Bourien

http://www.w3.org/2001/XMLSchema#string

Mario Campone

http://www.w3.org/2001/XMLSchema#string

Paule Augereau

http://www.w3.org/2001/XMLSchema#string

P2860

Cytotoxic chemotherapy: Still the mainstay of clinical practice for all subtypes metastatic breast cancer

Everolimus in postmenopausal hormone-receptor-positive advanced breast cancer

A phase I evaluation of the combination of vinflunine and erlotinib in patients with refractory solid tumors.

Vinflunine, the latest Vinca alkaloid in clinical development. A review of its preclinical anticancer properties.

Antimitotic and tubulin-interacting properties of vinflunine, a novel fluorinated Vinca alkaloid.

Phase III trial of vinflunine plus best supportive care compared with best supportive care alone after a platinum-containing regimen in patients with advanced transitional cell carcinoma of the urothelial tract.

Vinflunine: a new active drug for second-line treatment of advanced breast cancer. Results of a phase II and pharmacokinetic study in patients progressing after first-line anthracycline/taxane-based chemotherapy.

Vinflunine: a new microtubule inhibitor agent.

Fulvestrant plus palbociclib versus fulvestrant plus placebo for treatment of hormone-receptor-positive, HER2-negative metastatic breast cancer that progressed on previous endocrine therapy (PALOMA-3): final analysis of the multicentre, double-blind

A phase II trial of vinflunine as monotherapy or in combination with trastuzumab as first-line treatment of metastatic breast cancer.

P304

1817-1823

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1080/14656566.2016.1217991

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Jean-Sébastien Frénel

P577

2016-08-02T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27484180

http://www.w3.org/2001/XMLSchema#string

Vinflunine for the treatment of breast cancer.

about

P2860

P2860

Vinflunine for the treatment of breast cancer.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P50

P577

P698

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P50

P577

P698